济南强直性脊柱炎喝酒济南强制性脊柱炎晚期怎么治疗,山东治疗强直脊柱炎骨科医院如何,北京治疗老人类风湿性关节炎医院,山东中医治疗强直炎,济南强直性脊椎炎应做哪些检查,北京强直性脊柱炎针灸有效果吗,山东强直性脊柱炎早期可以治疗好吗

IWATE, Japan, March 14 (Xinhua) -- A 15-strong Chinese international search and rescue team Monday morning set out to join the relief work in Oofunato, Iwate, a city severely damaged by a 9.0-magnitude earthquake Friday.The Chinese international search and rescue team, which arrived in Oofunato at around 10:30 p.m. Sunday night, is the first overseas team to join and help out the relief work in the city.Team leader Yin Guangfui said they have brought along life exploration device and some other equipment to help carrying out the rescue.The team, with good experience in search and rescue, will strive to do the relief work, Yin added.The team members, including rescue and medical personnel, gathered at a primary school in Oofunato on Sunday and set off at 7:30 a.m. to the disaster-hit area together with the Japanese rescue teams after a briefing. The team is expected to be here for seven to 10 days.The catastrophic earthquake hit northeast of Japan on March 11, triggering severe tsunami and causing extensive damage and loss in different areas. According to local media, a total of 985 people have been confirmed dead, 707 others injured and over 1,700 others missing.

WASHINGTON, May 25 (Xinhua) -- Two U.S. astronauts conducted the third of four scheduled spacewalks for space shuttle Endeavour 's STS-134 mission on Wednesday morning, the U.S. National Aeronautics and Space Administration (NASA) announced.Endeavour's mission specialists Drew Feustel and Mike Fincke completed a six-hour-54-minute spacewalk at 8:37 a.m. EDT (1437 GMT). They completed all planned tasks, installing cables to increase redundancy for the power system on the Russian segment of the station, completing the external wireless antenna system work Feustel and Greg Chamitoff began during the first spacewalk, and installing a power and data grapple fixture to Zarya. The fixture will allow the station's robotic arm to "walk" to the Russian segment, extending its reach by using that grapple fixture as a base.It was the 247th spacewalk conducted by U.S. astronauts, and the 158th in support of space station assembly and maintenance, totaling 995 hours and 13 minutes. If everything goes as planned, the 1,000th hour of space station assembly and maintenance will be logged on Friday.Endeavour lifted off on May 16 from the Kennedy Space Center in Florida, to deliver to the International Space Station a 2-billion- dollar, multinational particle detector known as the Alpha Magnetic Spectrometer (AMS).AMS, a particle physics detector, is designed to search for various types of unusual matter by measuring cosmic rays. Its experiments are designed to help researchers study the formation of the universe and search for evidence of dark matter, strange matter and antimatter.NASA's 30-year-old shuttle program is ending due to high operating costs. The Obama administration wants to spur private companies to get into the space taxi business, freeing NASA to focus on deep space exploration and new technology development.There were initially five space shuttles in the fleet -- Challenger exploded shortly after liftoff in 1986 and Columbia disintegrated on its way back to Earth in 2003. Discovery retired earlier this year, while Endeavour is currently on its final mission. A last mission for Atlantis is scheduled for July, though funding for Atlantis remains in question.The sixth shuttle, Enterprise, did test flights in the atmosphere but was never flown into space. It is already on display at a museum outside Washington.When the U.S. space shuttle program officially ends later this year, the Russian space program's Soyuz capsule will be the only method for transporting astronauts to and from the station.

BEIJING, May 28 (Xinhua) -- The issue of third-party online payment permits in China this week will boost the sector's development through giving it a legal status, analysts said.The People's Bank of China (PBOC), or the central bank, on Thursday announced its first batch of electronic payment licenses to 27 qualified third-party online payment platforms, including Alipay, Tenpay and 99bill.It also stipulated that all the third-party payment businesses should obtain licenses before September, or cease doing business.The move has long been awaited after the central bank said in June last year that non-financial institution payment service would be regulated, and that all businesses involved in the service must get licenses before Sept. 1, 2011.The license covers payment transactions such as Internet payment, mobile phone payment, bank card acquiring service, issuance and accept of prepaid cards and currency exchange.The move provides a legal status for the third-party payment sector so that it can develop in a more standard and healthy way, said Zhang Meng, an analyst with Analysys International, an Internet market information provider.Third-party payment enterprises refer to those non-financial operators who work as the third party between buyers and sellers to provide payment settlement through Internet, telephones or mobile phones.China has the world's highest number of Internet users, with about 457 million netizens, among whom 148 million were active online shoppers as of the end of last year.China's online payment topped 1.09 trillion yuan (167.29 billion U.S. dollars) last year. The figure was 397.3 billion yuan in the first quarter this year, almost doubled year-on-year.99bill CEO Guan Guoguang called the issue of the third-party payment licenses "a milestone" for China's e-payment sector.Requiring that enterprises must be licensed to operate e-payment businesses will help standardize the sector, improve services and boost integration of e-payment and e-commerce, said Guan.The first group of e-payment license holders include Alipay.com Co. Ltd, a unit of Alibaba Group Holding which owns the country's largest e-commerce website Alibaba.com Co. Ltd.; China UMS, a unit of China UnionPay Co. Ltd; Tenpay.com, an e-payment platform developed by Chinese Internet giant Tencent Holdings and Shengfutong, launched by Shanda Interactive Entertainment.Five applicants, however, failed to get licenses.Businesses with licenses will attract more investment and high-end personnel, says iResearch analyst Cheng Shanbao.For those without a license, they will be merged or have to pull out of the sector, according to Yeepay CEO Tang Bin.The central bank selected enterprises that have good management and risk control systems, as well as profit prospects, Zhang Meng said.Mergers are inevitable as the cut-off date of Sept. 1 is approaching, he added.The third-party payment enterprises mainly profit from 1 to 4 percent fees, but analysts believe profits from the fees might be reduced due to fierce competition.

WELLINGTON, May 13 (Xinhua) -- While it's long been known that a little sunshine can spread happiness, researchers in New Zealand have found that it can also save the lives of pneumonia patients.Medical scientists have found that vitamin D, which is absorbed through the skin and produced with exposure to sunlight, is a major factor in the survival rate of pneumonia patients.Researchers at Waikato University collaborated with doctors at Waikato Hospital, both Hamilton-based institutions, to study blood samples of 112 patients admitted to the hospital with pneumonia during the winter.They found that those with severe vitamin D deficiency 17 of the patients were more likely to die within a month, compared with patients with normal or slightly low vitamin D levels.Dr Bob Hancox, of the hospital's department of respiratory medicine, said five of the 17 died, a 29-percent mortality rate, compared with four deaths among the 95 patients with higher vitamin D levels, a 4-percent mortality rate."The analysis confirmed that the difference in mortality rates between the two groups was very unlikely to be due to chance," Hancox told Xinhua.Vitamin D deficiency was a concern around the world, Hancox said."Sunlight is the main source of vitamin D, so it tends to be a winter problem in temperate climates when people spend a lot of time indoors. But it occurs in all countries and vitamin D deficiency is believed to be a major problem worldwide."There is accumulating evidence that we need vitamin D to help fight infections, such as pneumonia as we have shown, as well as improve bone health," he told Xinhua."What is not yet clear is whether we can do anything about it. We don't know whether treating people with vitamin D supplements would help to prevent or treat respiratory infections. This is what we need to find out now."Dr Ray Cursons, of the Biological Sciences department at Waikato University, said patient age, sex, additional health conditions, and other prognostic factors did not affect the research outcome, although researchers still could not establish a causal link between vitamin D deficiency and mortality in the patients.Waikato Hospital D respiratory specialist Dr Noel Karalus said it was not yet known whether giving patients vitamin D supplements after their admission to hospital with respiratory tract infections would alter outcomes."It may transpire that vitamin D helps us avoid infection rather than cure it once established."Cursons said the best source of vitamin D was sunlight as dietary sources such as fatty fish and cod liver oil did not contain enough vitamin D."There is still some controversy regarding the optimal daily allowance of vitamin D. How much we absorb through the skin depends on sun exposure, skin type and geographical latitude. M ori and Pacific Islanders absorb less because of their darker skin, and people in colder climates also have lower levels of vitamin D. "Pneumonia is the single largest cause of death in children worldwide, killing an estimated 1.6 million children under the age of five each year, according to the World Health Organization.The research findings are published in the journal Respirology, published by the Asian Pacific Society of Respirology, this month.

WASHINGTON, May 11 (Xinhua) -- Researchers at Brigham and Women 's Hospital (BWH), a teaching affiliate of Harvard Medical School, have identified a human lung stem cell that is self-renewing and capable of forming and integrating multiple biological structures of the lung. This research will be published Thursday in the New England Journal of Medicine."This research describes, for the first time, a true human lung stem cell. The discovery of this stem cell has the potential to offer those who suffer from chronic lung diseases a totally novel treatment option by regenerating or repairing damaged areas of the lung," said the study's corresponding author Piero Anversa, who is also director of the Center for Regenerative Medicine at the hospital.Using lung tissue from surgical samples, researchers identified and isolated the human lung stem cell and tested the functionality of the stem cell both in vitro and in vivo. Once the stem cell was isolated, researchers demonstrated in vitro that the cell was capable of dividing both into new stem cells and also into cells that would grow into various types of lung tissue. Next, researchers injected the stem cell into mice with damaged lungs. The injected stem cells differentiated into new bronchioles, alveoli and pulmonary vessel cells which not only formed new lung tissue, but also integrated structurally to the existing lung tissue in the mice.The researchers define this cell as truly "stem" because it fulfills the three categories necessary to fall under stem cell categorization: first, the cell renews itself; second, it forms into many different types of lung cells; and third, it is transmissible, meaning that after a mouse was injected with the stem cells and responded by generating new tissue, researchers were then able to isolate the stem cell in the treated mouse, and use that cell in a new mouse with the same results."These are the critical first steps in developing clinical treatments for those with lung disease for which no therapies exist. Further research is needed, but we are excited about the impact this discovery could have on our ability to regenerate or recreate new lung tissues to replace damaged areas of the lungs," said Joseph Loscalzo, chair of the Department of Medicine at BWH and co-author.